Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-10-01
著者
-
Reesink Henk
Department Of Hepatology Academic Medical Center
-
WEEGINK Christine
Department of Hepatology, Academic Medical Center
-
CHAMULEAU Robert
Department of Hepatology, Academic Medical Center
-
MOLENAAR Delmar
Department of Neurology, Academic Medical Center
-
Chamuleau Robert
Department Of Hepatology Academic Medical Center
-
Weegink Christine
Department Of Hepatology Academic Medical Center
-
Molenaar Delmar
Department Of Neurology Academic Medical Center
関連論文
- Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
- Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C